Yoshimura-Uchiyama C, Iikura M, Yamaguchi M, Nagase H, Ishii A, Matsushima K, Yamamoto K, Shichijo M, Bacon K B, Hirai K
Department of Allergy and Rheumatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Clin Exp Allergy. 2004 Aug;34(8):1283-90. doi: 10.1111/j.1365-2222.2004.02027.x.
Both prostaglandin (PG) D receptor (DP) and CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells)/DP2 are high-affinity receptors for PGD2. Previous studies have demonstrated that PGD2 enhances releasability and induces CRTH2/DP2-mediated migration in human basophils, but the precise effects of PGD2 on basophils as well as receptor usage have not been fully clarified.
We comprehensively explored the roles of DP and CRTH2/DP2 in basophil functions by using selective agonists and antagonists for each receptor.
DP and CRTH2/DP2 transcripts were quantified by real-time PCR. We studied the effects of selective agonists (DP: BW245C; CRTH2/DP2: 13,14-dihydro-15-keto (DK)-PGD2) and/or antagonists (DP: BWA868C; CRTH2/DP2: ramatroban) on Ca2+ mobilization, migration, degranulation, CD11b expression and survival of human basophils.
Basophils expressed transcripts of both DP and CRTH2/DP2, but the levels of CRTH2/DP2 transcripts were ca. 100-fold higher compared with DP transcripts. Ca2+ influx was induced in basophils by either PGD2 or DK-PGD2/CRTH2 agonist but not by BW245C/DP agonist. Basophils treated with PGD2 were completely desensitized to subsequent stimulation with DK-PGD2, but not vice versa. DK-PGD2 as well as PGD2 up-regulated CD11b expression, induced migration and enhanced degranulation, and those effects were completely antagonized by ramatroban/CRTH2 antagonist. In contrast, BW245C/DP agonist exhibited an inhibitory effect on basophil migration and IgE-mediated degranulation, and the migration inhibitory effect was effectively antagonized by BWA868C/DP antagonist. On the other hand, while PGD2 significantly shortened the basophil life-span, neither DK-PGD2/CRTH2 agonist nor BW245C/DP agonist did.
CRTH2/DP2 is primarily responsible for the pro-inflammatory effects of PGD2 on human basophils, while DP introduces negative signals capable of antagonizing the effects of CRTH2/DP2 in these cells. The effects of PGD2 on longevity imply a mechanism(s) other than via DP or CRTH2/DP2. CRTH2/DP2 on basophils may afford opportunities for therapeutic targeting in allergic inflammation.
前列腺素(PG)D受体(DP)和CRTH2(Th2细胞上表达的趋化因子受体同源分子)/DP2都是PGD2的高亲和力受体。先前的研究表明,PGD2可增强人嗜碱性粒细胞的释放能力并诱导CRTH2/DP2介导的迁移,但PGD2对嗜碱性粒细胞的确切作用以及受体的使用情况尚未完全阐明。
我们通过使用每种受体的选择性激动剂和拮抗剂,全面探讨了DP和CRTH2/DP2在嗜碱性粒细胞功能中的作用。
通过实时PCR对DP和CRTH2/DP2转录本进行定量分析。我们研究了选择性激动剂(DP:BW245C;CRTH2/DP2:13,14-二氢-15-酮(DK)-PGD2)和/或拮抗剂(DP:BWA868C;CRTH2/DP2:雷马曲班)对人嗜碱性粒细胞钙离子动员、迁移、脱颗粒、CD11b表达和存活的影响。
嗜碱性粒细胞表达DP和CRTH2/DP2的转录本,但CRTH2/DP2转录本的水平比DP转录本高约100倍。PGD2或DK-PGD2/CRTH2激动剂均可诱导嗜碱性粒细胞内钙离子流入,而BW245C/DP激动剂则不能。用PGD2处理的嗜碱性粒细胞对随后的DK-PGD2刺激完全脱敏,但反之则不然。DK-PGD2以及PGD2均可上调CD11b表达、诱导迁移并增强脱颗粒,而这些作用均被雷马曲班/CRTH2拮抗剂完全拮抗。相比之下,BW245C/DP激动剂对嗜碱性粒细胞迁移和IgE介导的脱颗粒具有抑制作用,而BWA868C/DP拮抗剂可有效拮抗其迁移抑制作用。另一方面,虽然PGD2可显著缩短嗜碱性粒细胞的寿命,但DK-PGD2/CRTH2激动剂和BW245C/DP激动剂均无此作用。
CRTH2/DP2主要负责PGD2对人嗜碱性粒细胞的促炎作用,而DP则引入负性信号,能够拮抗这些细胞中CRTH2/DP2的作用。PGD2对细胞寿命的影响意味着存在一种不同于通过DP或CRTH2/DP2的机制。嗜碱性粒细胞上的CRTH2/DP2可能为过敏性炎症的治疗靶点提供机会。